Compounds, compositions and methods are provided for modulating the
expression of Tudor-SN. The compositions comprise oligonucleotides,
targeted to nucleic acid encoding Tudor-SN. Methods of using these
compounds for modulation of Tudor-SN expression and for diagnosis and
treatment of diseases and conditions associated with expression of
Tudor-SN are provided.